日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone

重组H77C gpE1/gpE2异二聚体比单独的H77C gpE2具有更强的HCV交叉中和能力。

Kundu, Juthika; Le, Hoa T; Logan, Michael; Hockman, Darren; Landi, Abdolamir; Crawford, Kevin; Wininger, Mark; Johnson, Janelle; Kundu, Joydeb K; Tiffney, E Alana; Urbanowicz, Richard A; Ball, Jonathan K; Bailey, Justin R; Bukh, Jens; Law, Mansun; Foung, Steven; Tyrrell, D Lorne; Houghton, Michael; Law, John Lokman

Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins

不同佐剂对HCV包膜糖蛋白体液和细胞免疫反应的持久性和强度的影响

Akache, Bassel; Deschatelets, Lise; Harrison, Blair A; Dudani, Renu; Stark, Felicity C; Jia, Yimei; Landi, Amir; Law, John L M; Logan, Michael; Hockman, Darren; Kundu, Juthika; Tyrrell, D Lorne; Krishnan, Lakshmi; Houghton, Michael; McCluskie, Michael J

Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus

利用计算机预测丙型肝炎病毒编码的gpE1/gpE2包膜糖蛋白的异二聚体和高级结构

Freedman, Holly; Logan, Michael R; Hockman, Darren; Koehler Leman, Julia; Law, John Lok Man; Houghton, Michael

Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.

重组丙型肝炎病毒包膜糖蛋白疫苗可诱导产生针对包膜糖蛋白上多个表位的抗体,从而实现广泛的交叉中和作用

Wong Jason Alexander Ji-Xhin, Bhat Rakesh, Hockman Darren, Logan Michael, Chen Chao, Levin Aviad, Frey Sharon E, Belshe Robert B, Tyrrell D Lorne, Law John Lok Man, Houghton Michael

Enhanced activation of memory, but not naïve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis

慢性丙型肝炎病毒感染合并冷球蛋白血症和晚期肝纤维化患者的记忆性B细胞(而非初始B细胞)活化增强

Santer, Deanna M; Ma, Mang M; Hockman, Darren; Landi, Abdolamir; Tyrrell, D Lorne J; Houghton, Michael